SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Edison Pharmaceuticals, Inc. & Bambino Gesu Children's Hospital Announce Initiation of EPI-743 Phase 2 Cobalamin C Deficiency Syndrome Clinical Trial